West Pharmaceutical Services Inc
NYSE:WST
West Pharmaceutical Services Inc
Revenue
West Pharmaceutical Services Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
West Pharmaceutical Services Inc
Revenue Breakdown
Breakdown by Geography
West Pharmaceutical Services Inc
Total Revenue:
2.9B
USD
|
United States:
1.2B
USD
|
Germany:
406.1m
USD
|
Other European Countries:
388.1m
USD
|
Other:
348.5m
USD
|
Ireland:
285.7m
USD
|
France:
282.9m
USD
|
Breakdown by Segments
West Pharmaceutical Services Inc
Total Revenue:
2.9B
USD
|
Proprietary Products:
2.4B
USD
|
Contract Manufactured Products:
552.5m
USD
|
See Also
What is West Pharmaceutical Services Inc's Revenue?
Revenue
2.9B
USD
Based on the financial report for Mar 31, 2024, West Pharmaceutical Services Inc's Revenue amounts to 2.9B USD.
What is West Pharmaceutical Services Inc's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for West Pharmaceutical Services Inc have been 8% over the past three years , 11% over the past five years , and 8% over the past ten years .